Aim: To investigate the effects of the interaction between glycated haemoglobin (HbA1c) genetic risk score and weight changes during and after pregnancy (postpartum weight reduction and gestational weight gain) on long-term glycaemic changes in the largest cohort of women with a history of gestational diabetes mellitus (GDM).
| INTRODUCTION
During pregnancy, women will gain approximately ≥20% body weight. 1 Abnormal glucose metabolism is greatly affected by weight changes during and after pregnancy. 2, 3 Compelling evidence indicates that low postpartum weight reduction is associated with aberrant glucose metabolism and an increased risk of type 2 diabetes in later life, 1, [4] [5] [6] [7] and women with greater postpartum weight retention preceded by gestational diabetes mellitus (GDM) are at greater risk of this metabolic disease. [8] [9] [10] [11] Glycated haemoglobin (HbA1c) level is regarded as a stable biomarker for hyperglycaemia. Genetic susceptibility to higher HbA1c levels had been verified by genome-wide association studies (GWASs) 12, 13 ; however, the effect of interactions between genetic variations in HbA1c level and weight changes during and after pregnancy (gestational weight gain and postpartum weight reduction) on long-term changes in glycaemic variables remain unclear. We hypothesized that weight changes during and after pregnancy (gestational weight gain and postpartum weight reduction) might modify the effect of genetic variations of HbA1c on glycaemic changes.
We investigated the interaction effect between HbA1c genetic risk score and weight changes during and after pregnancy (postpartum weight reduction and gestational weight gain) on long-term changes in glycaemic traits in the largest cohort of women with a history of GDM.
| MATERIALS AND METHODS

| Study sample
This was a retrospective cohort study, using baseline data from the Tianjin Gestational Diabetes Mellitus Prevention Programme. 14 
| Tianjin Gestational Diabetes Mellitus Screening Programme
The ongoing Tianjin Gestational Diabetes Mellitus Prevention Programme is a 2-arm, 4-year randomized controlled trial, conducted by the Tianjin Women's and Children's Health Centre, Tianjin, China (ClinicalTrials.gov: NCT01554358). The study comprises two groups, a usual care group and an intervention group. The intervention involves six face-to-face sessions with study dieticians in the first year, and two extra sessions and two telephone calls in the second year.
Detailed information on the study design has been described previously. 14 Of the 1263 women with a history of GDM who completed the questionnaire, 1180 were randomly assigned (1:1) to receive a 4-year lifestyle intervention or standard care. 14 The present study was a retrospective analysis and the outcomes were changes in glycaemic traits between pregnancy and the baseline for the intervention trial. The intervention would therefore not have affected the present analyses.
| Definition of study variables
All participants completed a baseline self-administered questionnaire.
Pre-pregnancy weight, postpartum weight, and weight gain in pregnancy were self-reported. Baseline weight was measured by trained physicians. 14 Body weight and height were measured using the standardized protocol according to the WHO MONICA project. 18 Weight was measured to the nearest 0.1 kg and height (without shoes) to the nearest 0.1 cm.
Postpartum weight retention (weight change between prepregnancy and 1 to 5 years postpartum) was calculated using gestational weight gain and postpartum weight reduction. Annual postpartum weight reduction was calculated by dividing the difference between postpartum weight and predelivery weight (prepregnancy weight plus gestational weight gain) by follow-up years. 
| Calculation of HbA1c genetic risk score
DNA was extracted from the buffy coat fraction of centrifuged blood using a QIAamp Blood Maxi Kit (Qiagen, Chatsworth, California).
Single-nucleotide polymorphisms (SNPs) were genotyped by quantitative real-time TaqMan PCR (Applied Biosystems, Foster City, California), with a success rate ≥98%. The HbA1c genetic risk score was established by aggregating the HbA1c-increasing alleles according to the HbA1c susceptibility SNPs discovered by GWAS (Table S1) , 12, 13 and mutual independence was observed for all HbA1c SNPs. Among them, rs1800562 and rs855791 were not in accordance with HardyWeinberg equilibrium in our data, thus rs266717 and rs12597579
were used as proxies, respectively (r 2 = 1). The GWAS provided the β-coefficients (effect sizes) for the 10 HbA1c susceptibility SNPs 12, 13 ( Table S1 ). A genetic risk score was established by summing the 10 effect alleles, weighted by the β-coefficients. We transformed the β-coefficients to indicate a higher HbA1c. The HbA1c genetic risk score was divided into tertiles (tertile 1 for the lowest, and tertile 3 for the highest).
| Statistical analysis
We conducted a retrospective analysis using baseline data from the Tianjin Gestational Diabetes Mellitus Prevention Programme; the final analysis was restricted to a group of 1156 participants with available genotype data. The baseline characteristics across different groups of annual postpartum weight reduction (<5 kg/y, 5-8 kg/y and ≥8 kg/y) and gestational weight gain (inadequate, adequate, excessive) were estimated using χ 2 tests and general linear models (GLMs), as appropriate. The association of HbA1c genetic risk score and changes in glycaemic traits by annual weight reduction groups was tested using a GLM. The interaction effect between HbA1c genetic risk score and annual postpartum weight reduction on changes in glycaemic traits was tested by including an interaction term in the models. The longterm effects of weight changes on the glycaemic traits, stratified by tertile of HbA1c genetic risk score, were also estimated using GLMs.
In addition, sensitivity analyses were performed to estimate the effect of follow-up years on the observed association. SAS 9.4 was used to perform all of the analysis, with two-sided significance at 0.05 (SAS Institute, Cary, North Carolina).
| RESULTS
The characteristics of the women in the different postpartum weight reduction and gestational weight gain groups are summarized in Table 1 and Table S2 , respectively. Statistical differences in prepregnancy weight, pre-delivery weight and postpartum weight were evidenced across different groups of postpartum weight reduction.
Other characteristics and HbA1c genetic risk score were not significantly different among the groups ( Table 1 ).
The distribution of the HbA1c genetic risk score is shown in Figure S1 . There were no statistical differences for the HbA1c genetic risk scores and reference levels of glycaemic traits, even after adjustment for covariates. The associations between HbA1c genetic risk score and changes in glycaemic traits, stratified by annual postpartum weight reduction and gestational weight gain, are summarized in Table 2 and Table S3 , respectively. After adjusting for covariates, changes in HbA1c levels were only statistically significant in the postpartum weight reduction <5 kg/y group (P = 0.002; Table 2 ). Significant interactions were evident for the effect of association between HbA1c genetic risk score and postpartum weight reduction on changes in HbA1c (P interaction = 0.01). In the category of postpartum weight reduction ≥8 kg/y, women with a lower genetic predisposition to high HbA1c might be more susceptible to the improvement in HbA1c (P = 0.036). Along with the accumulation of HbA1c genetic risk score, elevated HbA1c was evident in the largest postpartum weight loss group ( Figure 1C ). In the group with postpartum weight reduction of <5 kg/y, HbA1c levels were decreased in all tertiles of HbA1c genetic risk score, whereas HbA1c levels were increased in the group with postpartum weight reduction of ≥8 kg/y ( Figure 1C ).
We also estimated the effects of HbA1c genetic risk score tertiles divided by weight reduction (kg/y) on changes in HbA1c level (Table S5 ). In the group with postpartum weight reduction of ≥8 kg/y, women with a lower genetic predisposition to high HbA1c levels showed greater improvement in HbA1c level (P = 0.036; Table S5 ).
We did not observe any significant interaction effects on changes in fasting glucose and 2-hour glucose levels, or among the different gestational weight gain groups (Table S2) . A sensitivity analysis was also performed by limiting the sample to participants with delivery within the first 1.5 years of the study HbA1c genetic risk score and postpartum weight reduction/gestational weight gain on any glycaemic changes were observed (Table 3 and Table S4 , respectively).
| DISCUSSION
We observed significant interaction effects between HbA1c genetic risk score and postpartum weight reduction on changes in HbA1c in, to our knowledge, the largest study cohort of women with a history of GDM. Our data show that, across different categories of postpartum weight reduction, the interaction effects of HbA1c genetic risk score differed significantly on changes in HbA1c levels. Interestingly,
In the group with postpartum weight reduction <5 kg/yr, HbA1c levels were decreased across tertiles of HbA1c genetic risk score, whereas HbA1c levels were increased in the group with postpartum weight reduction ≥8 kg/y. The results of the present study show that postpartum weight reduction might modify the effects of HbA1c genetic risk score on long-term HbA1c changes; the "vulnerability genes" of HbA1c may act as "plasticity genes," 20 with some women more susceptible to postpartum weight reduction, and others not. In the category of postpartum weight reduction ≥8 kg/y, women with a lower genetic predisposition to high HbA1c might be more susceptible to the improvement in HbA1c (P = 0.036).
Women with greater postpartum weight retention are more susceptible to insulin resistance. 21 Improvement in glucose metabolism in women with GDM was observed after moderate postpartum weight loss. 9 Low postpartum weight reduction contributes significantly to the long-term risk of type 2 diabetes in later life, especially in women with a history of GDM 1, [4] [5] [6] [7] ; therefore, postpartum weight reduction is of great importance in this population. 22, 23 The findings of the present study suggest that a genetic predispo- to their genetic background. We created an HbA1c genetic risk score using widely accepted methods to sum up the genetic variations, weighted by their effect sizes. 24, 25 Individual genetic variants explain a very small fraction of the overall variation, and a combination of a higher number of included variants with weak to moderate effect sizes into a genetic risk score explains a larger proportion of heritability. 26, 27 Two large GWASs were conducted to analyse the common genetic determinants of HbA1c levels with larger sample sizes and independent replications; the identified SNPs reached genome-wide significance levels (P < 5 × 10 −8 ), thus providing more reliable estimates. 12, 13 Currently, the construction of genetic risk scores uses the weighted published effect size from SNPs identified by GWASs that achieved genome-wide significance 28, 29 ; however, the SNPs in the present study did not reach the required levels; therefore, we used the weighted β-coefficients from the two large GWASs. 12, 13 The results were similar when we used the unweighted genetic risk scores.
The genetic architectures of HbA1c and fasting glucose were partially overlapping; the GWAS for fasting glucose suggested that SNPs near three loci (G6PC2, MTNR1B and GCK) were also associated with HbA1c levels 13 ; therefore, we not only investigated the effect of interaction between HbA1c genetic risk score and postpartum weight reduction on HbA1c changes, but also on changes of fasting glucose and 2-hour glucose levels.
The results of the present study should be interpreted with caution; the findings might not be generalizable to other populations, and further studies are required to verify them. In addition, the sample size of women in the sensitivity analysis was comparatively small, thus the interaction effect was not significant in this sub-group analysis. Furthermore, the genetic susceptibility of HbA1c SNPs was primarily determined in women of European ancestry, 12,13 which may not be representative of the genetic susceptibility of Chinese women with GDM.
Taken together, our results show an interaction effect of postpartum weight reduction with genetic predisposition to high HbA1c levels on long-term changes in HbA1c. In contrast to women with a higher genetic risk score, we observed a more distinct association between postpartum weight reduction and HbA1c improvement in women with a lower genetic risk score. In women genetically predisposed to high HbA1c levels, postpartum weight management is therefore of great importance.
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